2023 BrainChip Discussion, page-3574

BRN replied to my email....

Thank you for your email.

1. The lack of commercial IP sales agreements over the past 18 months has been the primary cause of the drop in share price.  The BRN share price was the subject of massive hype in late 2021/ early 2022 and a great many enthusiastic “momentum investors” pushed the Company’s share price well beyond what it was worth at the time.  Since then, we have seen a steady decline as the market has adjusted to the reality that building an IP company takes time, and developing and rolling out a commercialisation strategy for new technology also requires patience and persistence.  Since those heady days of $2 share price, our Company has developed its technology future, has strengthened our patent portfolio, built a commercial partnership ecosystem and continued to develop innovative new technologies that extend our competitive advantage, but these achievements are not reflected in our current share price.
2. Yes.  The management team has built a sales and marketing team to drive our commercialisation strategy and have added to that team over the past 12 months to ensure we now have a truly global sales team.  We have engaged with our customers and ecosystem partners and received significant and constructive feedback on improving our first-generation technology, which we have incorporate into our 2^nd generation technology.  Our focus is on delivering our second-generation technology, Akida 2.0 by late Q3.
3. See above
4. Delivering results where we can demonstrate widespread adoption by industry leaders of our technology and a clear pathway to the generation of sustainable income from IP royalties.
5. Engagements such as this happen all the time.  I am constantly communicating with shareholders, analysts and potential investors from around the world.

Regards

Tony Dawe